CNE000001HN2
CNE000001HN2
MAYINGLONG PHARMACEUTICAL GP CO
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q1 '26 31.03.2026 |
|---|---|---|
Market & Enterprise Value | ||
Market Cap | 9.89B EUR | 10.84B EUR |
Enterprise Value | 7.61B EUR | 9.96B EUR |
Valuation Multiples | ||
Trailing P/E | 16.51x | 17.04x |
Forward P/E | 15.51x | -- |
Price to Sales | 2.52x | 2.72x |
Price to Book | 2.23x | 2.36x |
EV/Revenue | 1.94x | 2.5x |
EV/EBITDA | 10.71x | 12.56x |
Price to FCF (P/FCF) | 36.87x | 19.72x |
EV/FCF | 28.35x | 18.12x |
FCF Yield | 2.71% | 5.07% |